Multiple Sclerosis Trial, Recruiting NCT04694534 Sponsor: Lille Catholic University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Recruiting

NCT04694534
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with relapsing-remitting or progressive multiple sclerosis (MS), based on recognised MS diagnostic guidelines
  • You are between 18 and 65 years old
  • You have noticed memory or thinking difficulties, and at least one test result from an initial cognitive (thinking/memory) assessment came back below the normal range, including at least one specific memory and thinking test called BICAMS
  • You have not had a definite MS relapse (flare-up) in the last 6 weeks
  • It has been at least 4 weeks since you last received a steroid treatment (given in high doses, often called a "bolus")
  • You are not currently taking antipsychotic medication (also called neuroleptics)
  • You have access to the internet at home or elsewhere
  • You are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • You have severe cognitive (thinking/memory) difficulties, specifically showing low scores in more than six different thinking or memory areas during the initial assessment
  • You are currently receiving neuropsychological therapy or treatment for memory and thinking difficulties
  • You are unable to understand spoken or written information
  • You are unable to use the computer software required for the trial, for example due to difficulties with movement or senses such as sight or touch
  • You have a neurological or psychiatric condition other than MS or mild-to-moderate anxiety or depression
  • You have severe anxiety or depression, based on a specific scoring scale (confirm with trial site)
  • You are already taking part in another clinical trial focused on cognitive (thinking/memory) functions
  • You are under any form of legal protection, guardianship, or supervised care arrangement
  • You are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bruno Lenne, Hôpital Saint-Vincent de Paul

Phone: 03.20.22.52.69

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lille Catholic University
Registry
ClinicalTrials.gov
Start date
8 October 2021
Est. completion
4 April 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Change in the California Verbal Learning Test (CVLT); Change in the Brief Visuo-spatial Memory Test (BVMT); Change in the Symbol Digit Modalities Test (SDMT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov